A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) With Temsirolimus in Children With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma (DIPG)
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Vorinostat (Primary) ; Temsirolimus
- Indications Glioma
- Focus Adverse reactions
- 05 Apr 2017 Trial design presented at the 108th Annual Meeting of the American Association for Cancer Research
- 07 Oct 2015 Planned primary completion date changed from 1 Aug 2018 to 1 Oct 2018, as reported by ClinicalTrials.gov.
- 07 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.